Evidence map›Paper›PMID 37680234›Full record

ArticleThe Lancet regional health. Europe2023

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden.

Kim Blom, Oscar Bladh, Sebastian Havervall, Ulrika Marking, Nina Greilert Norin, Jessica J Alm, Jonas Klingström, Charlotte Thålin

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet regional health. Europe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06784739 (COMMUNITY - the COVID-19 Immunity Study), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06784739 recruitingnot on this map

COMMUNITY - the COVID-19 Immunity Study

TypeobservationalSponsorDanderyd HospitalRan2020 to 2027Enrolled5,500ConditionsCOVID 19, Respiratory Synctial Virus, Influenza Virus, SARS-CoV-2 VirusArmsBlood sampling, Mucosal sampling, PCR-test
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kim BlomPublic Health Agency of Sweden, Solna, Sweden.
Oscar BladhDepartment of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Sebastian HavervallDepartment of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Ulrika MarkingDepartment of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Nina Greilert NorinDepartment of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Jessica J AlmDepartment of Microbiology, Tumor and Cell Biology (MTC) and National Pandemic Center, Karolinska Institutet, Solna, Sweden.
Jonas KlingströmPublic Health Agency of Sweden, Solna, Sweden.
Charlotte ThålinDepartment of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SELinköping University · SEPublic Health Agency of Sweden · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37680234
PMCPMC10480508
OpenAlexW4386300757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.